24
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Effect of chronic central endothelin-1 on hemodynamics and plasma vasopressin in conscious rats

, &
Pages 169-175 | Published online: 19 Jul 2013

References

  • Nakamura S, Naruse M, Naruse K, Shioda S, Nakai Y, Uemura H. Colocalization of immunoreactive endothelin-1 and neurohypophysial hormones in the axons of the neural lobe of the rat pituitary. Endocrinology 1993; 132: 530–3.
  • MacCumber MW, Ross CA, Glaser BM, Snyder SH. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 1989; 86: 7285–9.
  • Warner TD, Budzik GP, Matsumoto T, Mitchell JA, Förstermann U, Murad F. Regional differences in endothelin converting enzyme activity in rat brain: inhibition by phos-phoramidon and EDTA. Br J Pharmacol 1992; 106: 948–52.
  • Warner TD, Budzik GP, Mitchell JA, Huang ZJ, Murad F. Detection by bioassay and specific enzyme-linked immunosor-bent assay of phosphoramidon-inhibitable endothelin-convert-ing activity in brain and endothelium. J Cardiovasc Pharmacol 1992;20 Suppl 12: S19–21.
  • Sluck JM, Lin RC, Katolik LI, Jeng AY, Lehmann JC. Endothelin converting enzyme-1-, endothelin-1-, and endothe-lin-3-like immunoreactivity in the rat brain. Neuroscience 1999; 91: 1483-97.
  • Koseki C, Imai M, Hirata Y, Yanagisawa M, Masaki T. Autoradiographic localization of [i251]-endothelin-1 binding sites in rat brain. Neurosci Res 1989; 6: 581–5.
  • Yamada H, Kurokawa K. Histochemical studies on endothelin and the endothelin-A receptor in the hypothalamus. J Cardiovasc Pharmacol 1998;31 Suppl 1: 5215–8.
  • Shibata S, Himeno A, Shigematsu K, Tsutsumi K, Sakurai-Yamashita Y, Yamashita K. Endothelin receptors in rat pituitary gland. Cell Mol Neurobiol 1997; 17: 89–100.
  • Yamamoto T, Uemura H. Distribution of endothelin-B receptor-like immunoreactivity in rat brain, kidney, and pancreas. J Cardiovasc Pharmacol 1998;31 Suppl 1: 5207–11.
  • Kawano Y, Yoshida K, Yoshimi H, Kuramochi M, Omae T. The cardiovascular effect of intracerebroventricular endothelin in rats. J Hypertens Suppl 1989; 7: 522–3.
  • Yamamoto T, Kimura T, Ota K, Shoji M, Inoue M, Sato K, et al. Central effects of endothelin-1 on vasopressin release, blood pressure, and renal solute excretion. Am J Physiol 1992; 262: E856–62.
  • Mosqueda-Garcia R, Fernandez-Violante R, Hamakubo T, Stainback R. Vasopressin mediates the pressor effects of endothelin in the subfornical organ of the rat. J Pharmacol Exp Ther 1996; 277: 1034–42.
  • Matsumura K, Abel, Tsuchihashi T, Tominaga M, Kobayashi K, Fujishima M. Central effect of endothelin on neurohormonal responses in conscious rabbits. Hypertension 1991; 17: 1192–6.
  • Nishimura M, Takahashi H, Matsusawa M, Ikegaki I, Sakamoto M, Nakanishi T, et al. Chronic intracerebroventri-cular infusions of endothelin elevate arterial pressure in rats. J Hypertens 1991; 9: 71–6.
  • Yamamoto T, Kimura T, Ota K, Shoji M, Inoue M, Sato K, et al. Central effects of endothelin-1 on vasopressin and atrial natriuretic peptide release and cardiovascular and renal function in conscious rats. J Cardiovasc Pharmacol 1991;17 Suppl 7: S316–8.
  • Rossi NF, O'Leary DS, Chen H. Mechanisms of centrally administered ET-1-induced increases in systemic arterial pressure and AVP secretion. Am J Physiol 1997; 272: E126–32.
  • Rossi NF, Chen H. PVN lesions prevent the endothelin 1-induced increase in arterial pressure and vasopressin. Am J Physiol Endocrinol Metab 2001; 280: E349–56.
  • Rossi NF, O'Leary DS, Scislo TJ, Caspers ML, Chen H. Central endothelin 1 regulation of arterial pressure and arginine vasopressin secretion via the AV3V region. Kidney Int Suppl 1997; 61: S22–6.
  • Rossi NF, Chen H. Aminopropionic acid receptors in paraventricular nucleus mediate pressor and vasopressin responses to endothelin-1 in subfornical organ. Exp Biol Med (Maywood) 2006; 231: 1075-80.
  • Krieger EM. Neurogenic hypertension in the rat. Circ Res 1964; 15: 511–21.
  • Schreihofer AM, Sved AF. Use of sinoaortic denervation to study the role of baroreceptors in cardiovascular regulation. Am J Physiol 1994; 266: R1705–10.
  • Rossi NF. Effect of endothelin-3 on vasopressin release in vitro and water excretion in vivo in Long-Evans rats. J Physiol 1993; 461: 501–11.
  • Rossi NF, Schrier RW. Anti-calmodulin agents affect osmotic and angiotensin II-induced vasopressin release. Am J Physiol 1989; 256: E516–23.
  • Durnam DM, Palmiter RD. A practical approach for quantitating specific mRNAs by solution hybridization. Anal Biochem 1983; 131: 385–93.
  • Howard RL, Summer S, Rossi N, Kim JK, Schrier RW. Short-term hypothyroidism and vasopressin gene expression in the rat. Am J Kidney Dis 1992; 19: 573–7.
  • Giaid A, Gibson SJ, Herrero MT, Gentleman S, Legon S, Yanagisawa M, et al. Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry 1991; 95: 303–14.
  • Giaid A, Gibson SJ, Ibrahim BN, Legon S, Bloom SR, Yanagisawa M, et al. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci USA 1989; 86: 7634–8.
  • Takahashi K, Ghatei MA, Jones PM, Murphy JK, Lam HC, O'Halloran DJ, et al. Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J Clin Endocrinol Metab 1991; 72: 693–9.
  • Naidoo V, Naidoo S, Raidoo DM. Immunolocalisation of endothelin-1 in human brain. J Chem Neuroanat 2004; 27: 193–200.
  • Naidoo V, Mahabeer R, Raidoo DM. Cellular distribution of endothelin-1 mRNA in human brain by in situ RT-PCR. Metab Brain Dis 2001; 16: 207–18.
  • van den Buuse M, Itoh S. Central effects of endothelin on baroreflex of spontaneously hypertensive rats. J Hypertens 1993; 11: 379–87.
  • McQueen DS, Dashwood MR, Cobb VJ, Bond SM, Marr CG, Spyer KM. Endothelins and rat carotid body: autoradiographic and functional pharmacological studies. J Auton Nerv Syst 1995; 53: 115–25.
  • Spyer KM, McQueen DS, Dashwood MR, Sykes RM, Daly MB, Muddle JR. Localization of [125I]endothelin binding sites in the region of the carotid bifurcation and brainstem of the cat: possible baro- and chemoreceptor involvement. J Cardiovasc Pharmacol 1991;17 Suppl 7: S385–9.
  • Shibata S, Niwa M, Himeno A, Gana NG, Shigematsu K, Matsumoto M, et al. The endothelin ETA receptor exists in the caudal solitary tract nucleus of the rat brain. Cell Mol Neurobiol 1997; 17: 151–6.
  • Kohzuki M, Chai SY, Paxinos G, Karavas A, Casley DJ, Johnston CI, et al. Localization and characterization of endothelin receptor binding sites in the rat brain visualized by in vitro autoradiography. Neuroscience 1991; 42: 245–60.
  • Kohan DE, Rossi NF, Inscho EW, Pollock D. Regulation of blood pressure and salt homeostais by endothelin. Physiol Rev 2010; in press.
  • Mosqueda-Garcia R, Inagami T, Appalsamy M, Sugiura M, Robertson RM. Endothelin as a neuropeptide. Cardiovascular effects in the brainstem of normotensive rats. Circ Res 1993; 72: 20–35.
  • Rabkin R, Share L, Payne PA, Young J, Crofton J. The handling of immunoreactive vasopressin by the isolated perfused rat kidney. J Clin Invest 1979; 63: 6–13.
  • Shimizu K, Nakao A, Nonaka T, Oka H. Identification of vasopressin and determination of its corticomedullary levels in rat kidney tissue. Kidney Int 1984; 26: 785–90.
  • Rossi NF, Schrier RW. Role of arginine vasopressin in regulation of systemic arterial pressure. Annu Rev Med 1986; 37: 13–20.
  • Callahan MF, Ludwig M, Tsai KP, Sim LJ, Morris M. Baroreceptor input regulates osmotic control of central vasopressin secretion. Neuroendocrinology 1997; 65: 238–45.
  • Rossi NF, Chen H, Musch TI. Endothelin 1-induced pressor response and vasopressin release in rats with heart failure. J Cardiovasc Pharmacol 2002; 40: 80–9.
  • Rossi NF, Maliszewska-Scislo M, Chen H. Central endothelin: effects on vasopressin and the arterial baroreflex in doxorubicin heart failure rats. Can J Physiol Pharmacol 2008; 86: 343–52.
  • Zucker IH, Pliquett RU. Novel mechanisms of sympatho-excitation in chronic heart failure. Heart Fail Monit 2002; 3: 2–7.
  • Johnston CI. Vasopressin in circulatory control and hyperten-sion. J Hypertens 1985; 3: 557–69.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.